The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Peroxisome Proliferator-activated Receptor γ (PPARγ) as a Molecular Target for the Soy Phytoestrogen Genistein
Open accessAbstract
The principal soy phytoestrogen genistein has an array of biological actions. It binds to estrogen receptor (ER) alpha and beta and has ER-mediated estrogenic effects. In addition, it has antiestrogenic effects as well as non-ER-mediated effects such as inhibition of tyrosine kinase. Because of its complex biological actions, the molecular mechanisms of action of genistein are poorly understood. Here we show that genistein dose-dependently increases estrogenic transcriptional activity in mesenchymal progenitor cells, but its biological effects on osteogenesis and adipogenesis are different. At low concentrations (< or =1 microm), genistein acts as estrogen, stimulating osteogenesis and inhibiting adipogenesis. At high concentrations (>1 microm), however, genistein acts as a ligand of PPARgamma, leading to up-regulation of adipogenesis and down-regulation of osteogenesis. Transfection experiments show that activation of PPARgamma by genistein at the micromolar concentrations down-regulates its estrogenic transcriptional activity, while activation of ERalpha or ERbeta by genistein down-regulates PPARgamma transcriptional activity. Genistein concurrently activates two different transcriptional factors, ERs and PPARgamma, which have opposite effects on osteogenesis or adipogenesis. As a result, the balance between activated ERs and PPARgamma determines the biological effects of genistein on osteogenesis and adipogenesis. Our findings may explain distinct effects of genistein in different tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor β
Kuiper, G. G. J. M., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P. T., van der Burg, B., & Gustafsson, J.-Å. (1998) · Endocrinology · doi:10.1210/endo.139.10.6216 · Cited by 4,203
Genistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724
C/EBPα induces adipogenesis through PPARγ: a unified pathway
Rosen, E. D., Hsu, C.-H., Wang, X., Sakai, S., Freeman, M. W., Gonzalez, F. J., & Spiegelman, B. M. (2002) · Genes & Development · doi:10.1101/gad.948702 · Cited by 1,494
Phyto-oestrogens and Western Diseases
Adlercreutz, H., & Mazur, W. (1997) · Annals of Medicine · doi:10.3109/07853899709113696 · Cited by 1,279
PPARγ: a Nuclear Regulator of Metabolism, Differentiation, and Cell Growth
Rosen, E. D., & Spiegelman, B. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.r100034200 · Cited by 1,175
Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones
Kenneth, D. S. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1333s · Cited by 1,128
PPARδ Is an APC-Regulated Target of Nonsteroidal Anti-Inflammatory Drugs
He, T.-C., Chan, T. A., Vogelstein, B., & Kinzler, K. W. (1999) · Cell · doi:10.1016/s0092-8674(00)81664-5 · Cited by 1,085
Inhibition of Adipogenesis Through MAP Kinase-Mediated Phosphorylation of PPARγ
Hu, E., Kim, J. B., Sarraf, P., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5295.2100 · Cited by 1,050
Tham, D. M., Gardner, C. D., & Haskell, W. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4752 · Cited by 714
Interaction of Phytoestrogens with Estrogen Receptors .ALPHA. and .BETA..
MORITO, K., HIROSE, T., KINJO, J., HIRAKAWA, T., OKAWA, M., NOHARA, T., OGAWA, S., INOUE, S., MURAMATSU, M., & MASAMUNE, Y. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.351 · Cited by 614
Bianco, P., & Gehron Robey, P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10413 · Cited by 587
Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II.
Markovits, J., Linassier, C., Fossé, P., Couprie, J., Pierre, J., Jacquemin‐Sablon, A., Saucier, J.-M., Pecq, J. B. L., & Larsen, A. K. (1989) · PubMed · Cited by 550
Adams, M., Montague, C. T., Prins, J. B., Holder, J. C., Smith, S. A., Sanders, L., Digby, J. E., Sewter, C. P., Lazar, M. A., Chatterjee, V. K., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119870 · Cited by 517
Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2.
Lecka‐Czernik, B., Gubrij, I. B., Moerman, E. J., Kajkenova, O., Lipschitz, D. A., Manolagas, S. C., & Jilka, R. L. (1999) · PubMed · Cited by 464
Camp, H. S., & Tafuri, S. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10811 · Cited by 446
Lecka-Czernik, B., Moerman, E. J., Grant, D. F., Lehmann, J. M., Manolagas, S. C., & Jilka, R. L. (2002) · Endocrinology · doi:10.1210/endo.143.6.8834 · Cited by 441
Okura, A., Arakawa, H., Oka, H., Yoshinari, T., & Monden, Y. (1988) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(88)80030-5 · Cited by 437
Peroxisome Proliferator-Activated Receptors: From Genes to Physiology
Kliewer, S. A. (2001) · Recent Progress in Hormone Research · doi:10.1210/rp.56.1.239 · Cited by 425
Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPAR?2
Lecka-Czernik, B., Gubrij, I., Moerman, E. J., Kajkenova, O., Lipschitz, D. A., Manolagas, S. C., & Jilka, R. L. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19990901)74:3<357::aid-jcb5>3.0.co;2-7 · Cited by 405
Estrogen receptor β acts as a dominant regulator of estrogen signaling
Pettersson, K., Delaunay, F., & Gustafsson, J.-Å. (2000) · Oncogene · doi:10.1038/sj.onc.1203828 · Cited by 362
Ren, D., Collingwood, T. N., Rebar, E. J., Wolffe, A. P., & Camp, H. S. (2002) · Genes & Development · doi:10.1101/gad.953802 · Cited by 362
Helen, K., Greg Peterson, T., & Barnes, S. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/68.6.1418s · Cited by 309
Nuttall, M. E., & Gimble, J. M. (2000) · Bone · doi:10.1016/s8756-3282(00)00317-3 · Cited by 286
Evolution of the Health Benefits of Soy Isoflavones
Barnes, S. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44249 · Cited by 249
Peroxisome proliferator-activated receptor agonists
Willson, T. M., & Wahli, W. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80015-4 · Cited by 198
Exposure of KS483 Cells to Estrogen Enhances Osteogenesis and Inhibits Adipogenesis
Dang, Z. C., Van Bezooijen, R. L., Karperien, M., Papapoulos, S. E., & Löwik, C. W. G. M. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.3.394 · Cited by 179
Self-citationGenistein: does it prevent or promote breast cancer?
Bouker, K. B., & Hilakivi-Clarke, L. (2000) · Environmental Health Perspectives · doi:10.1289/ehp.00108701 · Cited by 160
Estrogen and Related Compounds: Biphasic Dose Responses
Calabrese, E. J. (2001) · Critical Reviews in Toxicology · doi:10.1080/20014091111785 · Cited by 112
Isoflavonoids and chronic disease: Mechanisms of action
Barnes, S., Boersma, B. J., Patel, R. P., Kirk, M., Darley-Usmar, V. M., Kim, H., & Xu, J. (2000) · BioFactors · doi:10.1002/biof.5520120133 · Cited by 109
Jackson, S. M., & Demer, L. L. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01372-7 · Cited by 88
Cloning of an osteoblastic cell line involved in the formation of osteoclast‐like cells
Yamashita, T., ASANO, K., Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Martin, T. J., & Suda, T. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041450327 · Cited by 87
Chan, G. K., Deckelbaum, R. A., Bolivar, I., Goltzman, D., & Karaplis, A. C. (2001) · Endocrinology · doi:10.1210/endo.142.11.8515 · Cited by 85
Beyond ERα and ERβ: Estrogen Receptor Binding Is Only Part of the Isoflavone Story
Barnes, S., Kim, H., Xu, J. U. N., Boersma, B. J., Darley-Usmar, V. M., Patel, R. P., & Luo, M. (2000) · Journal of Nutrition · doi:10.1093/jn/130.3.656s · Cited by 74
Lazar, M. A. (2002) · Genes & Development · doi:10.1101/gad.964002 · Cited by 59
Binding of prostaglandins to human PPARγ: tool assessment and new natural ligands
Ferry, G., Bruneau, V., Beauverger, P., Goussard, M., Rodriguez, M., Lamamy, V., Dromaint, S., Canet, E., Galizzi, J., & Boutin, J. A. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)00907-4 · Cited by 53
Self-citationShao, Z. M., Shen, Z. Z., Fontana, J. A., & Barsky, S. H. (2000) · PubMed · Cited by 47
Yamashita, T., Ishii, H., Shimoda, K., Sampath, T. K., Katagiri, T., Wada, M., Osawa, T., & Suda, T. (1996) · Bone · doi:10.1016/s8756-3282(96)00255-4 · Cited by 40
Rumi, M. A. K., Sato, H., Ishihara, S., Ortega, C., Kadowaki, Y., & Kinoshita, Y. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.125055 · Cited by 29
Sasaki, T., Fujimoto, Y., Tsuchida, A., Kawasaki, Y., Kuwada, Y., & Chayama, K. (2001) · Pathobiology · doi:10.1159/000064336 · Cited by 13
Cited by
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585
Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2003-0567 · Cited by 876
Environmental Obesogens: Organotins and Endocrine Disruption via Nuclear Receptor Signaling
Grün, F., & Blumberg, B. (2006) · Endocrinology · doi:10.1210/en.2005-1129 · Cited by 810
Natural product agonists of peroxisome proliferator-activated receptor gamma (PPARγ): a review
Wang, L., Waltenberger, B., Pferschy-Wenzig, E.-M., Blunder, M., Liu, X., Malainer, C., Blazevic, T., Schwaiger, S., Rollinger, J. M., Heiss, E. H., et al. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.07.018 · Cited by 594
Mezei, O., Shay, N., Banz, W. J., Steger, R. W., Peluso, M. R., & Winters, T. A. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.5.1238 · Cited by 401
Metadata
- Authors
- Dang, Z.-C., Audinot, V., Papapoulos, S. E., Boutin, J. A., & Löwik, C. W. G. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-01
- Volume
- 278
- Issue
- 2
- Pages
- 962-967
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2116512075
- Cited by
- 323
- References
- 39
- FWCI
- 10.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.